Community health worker-led household screening and management of neonatal hyperbilirubinemia in rural Bangladesh: a cluster randomized control trial protocol.

Gates Open Research Pub Date : 2024-01-05 eCollection Date: 2023-01-01 DOI:10.12688/gatesopenres.14033.2
Eric M Foote, Farjana Jahan, Mahbubur Rahman, Sarker Masood Parvez, Tasnim Ahmed, Rezaul Hasan, Farzana Yeasmin, Shams El Arifeen, Sk Masum Billah, Md Mahbubul Hoque, Mohammod Shahidullah, Muhammad Shariful Islam, Vinod K Bhutani, Gary L Darmstadt
{"title":"Community health worker-led household screening and management of neonatal hyperbilirubinemia in rural Bangladesh: a cluster randomized control trial protocol.","authors":"Eric M Foote, Farjana Jahan, Mahbubur Rahman, Sarker Masood Parvez, Tasnim Ahmed, Rezaul Hasan, Farzana Yeasmin, Shams El Arifeen, Sk Masum Billah, Md Mahbubul Hoque, Mohammod Shahidullah, Muhammad Shariful Islam, Vinod K Bhutani, Gary L Darmstadt","doi":"10.12688/gatesopenres.14033.2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Extreme hyperbilirubinemia leading to neurologic disability and death is disproportionately higher in low- and middle-income countries (LMIC) such as Bangladesh, and is largely preventable through timely treatment. In LMICs, an estimated half of all newborns are born at home and few receive screening or treatment for hyperbilirubinemia, leading to 6 million newborns per year who need phototherapy treatment for hyperbilirubinemia but are untreated. Household screening and treatment for neonatal hyperbilirubinemia with phototherapy administered by a trained community health worker (CHW) may increase indicated treatment for neonatal hyperbilirubinemia in comparison to the existing care system in Bangladesh.</p><p><strong>Methods: </strong>530 Bangladeshi women in their second or third trimester of pregnancy from the rural community of Sakhipur, Bangladesh will be recruited for a cluster randomized trial and randomized to the intervention arm - home screening and treatment for neonatal hyperbilirubinemia - or the comparison arm to receive usual care. In the intervention arm, CHWs will provide mothers with two prenatal visits, visit newborns by 2 days of age and then daily for 3 days to measure transcutaneous bilirubin (TcB) and monitor for clinical danger signs. Newborns without danger signs but with a TcB above the treatment threshold, but >15 mg/dL will be treated with light-emitting diode (LED) phototherapy at home. Newborns with danger signs or TcB ≥15 mg/dL will be referred to a hospital for treatment. Treatment rates for neonatal hyperbilirubinemia in each arm will be compared.</p><p><strong>Conclusion: </strong>This study will evaluate the effectiveness of CHW-led home phototherapy to increase neonatal hyperbilirubinemia treatment rates in rural Bangladesh. LMICs are expanding access to postnatal care by using CHWs, and our work will give CHWs a curative treatment option for neonatal hyperbilirubinemia. Similar projects in other LMICs can be pursued to dramatically extend healthcare access to vulnerable newborns with hyperbilirubinemia.</p>","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":"7 ","pages":"58"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249711/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gates Open Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/gatesopenres.14033.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Extreme hyperbilirubinemia leading to neurologic disability and death is disproportionately higher in low- and middle-income countries (LMIC) such as Bangladesh, and is largely preventable through timely treatment. In LMICs, an estimated half of all newborns are born at home and few receive screening or treatment for hyperbilirubinemia, leading to 6 million newborns per year who need phototherapy treatment for hyperbilirubinemia but are untreated. Household screening and treatment for neonatal hyperbilirubinemia with phototherapy administered by a trained community health worker (CHW) may increase indicated treatment for neonatal hyperbilirubinemia in comparison to the existing care system in Bangladesh.

Methods: 530 Bangladeshi women in their second or third trimester of pregnancy from the rural community of Sakhipur, Bangladesh will be recruited for a cluster randomized trial and randomized to the intervention arm - home screening and treatment for neonatal hyperbilirubinemia - or the comparison arm to receive usual care. In the intervention arm, CHWs will provide mothers with two prenatal visits, visit newborns by 2 days of age and then daily for 3 days to measure transcutaneous bilirubin (TcB) and monitor for clinical danger signs. Newborns without danger signs but with a TcB above the treatment threshold, but >15 mg/dL will be treated with light-emitting diode (LED) phototherapy at home. Newborns with danger signs or TcB ≥15 mg/dL will be referred to a hospital for treatment. Treatment rates for neonatal hyperbilirubinemia in each arm will be compared.

Conclusion: This study will evaluate the effectiveness of CHW-led home phototherapy to increase neonatal hyperbilirubinemia treatment rates in rural Bangladesh. LMICs are expanding access to postnatal care by using CHWs, and our work will give CHWs a curative treatment option for neonatal hyperbilirubinemia. Similar projects in other LMICs can be pursued to dramatically extend healthcare access to vulnerable newborns with hyperbilirubinemia.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
孟加拉国农村地区由社区卫生工作者主导的新生儿高胆红素血症家庭筛查和管理:分组随机对照试验方案。
背景:在孟加拉国等中低收入国家,极度高胆红素血症导致神经系统残疾和死亡的比例过高,而及时治疗在很大程度上是可以预防的。在低收入和中等收入国家,估计有一半的新生儿是在家中出生的,很少有人接受高胆红素血症筛查或治疗,这导致每年有 600 万新生儿需要光疗治疗高胆红素血症,但却得不到治疗。与孟加拉国现有的护理系统相比,由受过培训的社区保健员(CHW)进行新生儿高胆红素血症的家庭筛查和光疗治疗可能会增加新生儿高胆红素血症的治疗指征。方法:我们将从孟加拉国 Sakhipur 农村社区招募 530 名处于孕期第二或第三季度的孟加拉国妇女进行分组随机试验,并将她们随机分配到干预组(新生儿高胆红素血症的家庭筛查和治疗)或对比组(接受常规护理)。在干预组中,保健工作者将为母亲提供两次产前检查,并在新生儿出生 2 天前进行探视,然后在 3 天内每天测量经皮胆红素(TcB)并监测临床危险征兆。没有危险征兆但 TcB 超过治疗阈值但>15 mg/dL 的新生儿将在家中接受发光二极管 (LED) 光疗。有危险征兆或 TcB≥15 mg/dL 的新生儿将被转诊到医院接受治疗。将比较各组新生儿高胆红素血症的治疗率:这项研究将评估在孟加拉国农村地区,由社区保健工作者主导的家庭光疗对提高新生儿高胆红素血症治疗率的效果。低收入与中等收入国家正在利用保健工作者扩大产后护理的覆盖面,而我们的工作将为保健工作者提供一种治疗新生儿高胆红素血症的方法。可以在其他低收入国家和地区开展类似的项目,以大幅扩大对患有高胆红素血症的脆弱新生儿的医疗服务。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gates Open Research
Gates Open Research Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
CiteScore
3.60
自引率
0.00%
发文量
90
期刊最新文献
Developing a framework for understanding policy decision-making behaviors in the transition of an HIV prevention program towards sustainability: a case study from Zambia's voluntary medical male circumcision program. Knowledge and uptake of contraceptive and other sexual reproductive health services among in-school adolescents in three South African townships: Baseline findings from the Girls Achieve Power (GAP Year) Trial. Using models and maps to inform Target Product Profiles and Preferred Product Characteristics: the example of Wolbachia replacement. Vaccine decision-making among pregnant women: a protocol for a cross-sectional mixed-method study in Brazil, Ghana, Kenya and Pakistan. Simulated data for census-scale entity resolution research without privacy restrictions: a large-scale dataset generated by individual-based modeling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1